| Year |
Citation |
Score |
| 2023 |
Kim J, Naqvi AS, Corbett RJ, Kaufman RS, Vaksman Z, Brown MA, Miller DP, Phul S, Geng Z, Storm PB, Resnick AC, Stewart DR, Rokita JL, Diskin SJ. AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification. Biorxiv : the Preprint Server For Biology. PMID 38076939 DOI: 10.1101/2023.11.29.569103 |
0.661 |
|
| 2023 |
Kim J, Vaksman Z, Egolf LE, Kaufman R, Evans JP, Conkrite KL, Danesh A, Lopez G, Randall MP, Dent MH, Farra LM, Menghani NL, Dymek M, Desai H, Hausler R, ... ... Diskin SJ, et al. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. Journal of the National Cancer Institute. PMID 37688579 DOI: 10.1093/jnci/djad183 |
0.672 |
|
| 2023 |
Randall MP, Egolf LE, Vaksman Z, Samanta M, Tsang M, Groff D, Evans JP, Rokita JL, Layeghifard M, Shlien A, Maris JM, Diskin SJ, Bosse KR. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. Journal of the National Cancer Institute. PMID 37688570 DOI: 10.1093/jnci/djad182 |
0.711 |
|
| 2023 |
Shapiro JA, Gaonkar KS, Spielman SJ, Savonen CL, Bethell CJ, Jin R, Rathi KS, Zhu Y, Egolf LE, Farrow BK, Miller DP, Yang Y, Koganti T, Noureen N, Koptyra MP, ... ... Diskin SJ, et al. OpenPBTA: The Open Pediatric Brain Tumor Atlas. Cell Genomics. 3: 100340. PMID 37492101 DOI: 10.1016/j.xgen.2023.100340 |
0.682 |
|
| 2023 |
Randall MP, Egolf LE, Vaksman Z, Samanta M, Tsang M, Groff D, Evans JP, Rokita JL, Layeghifard M, Shlien A, Maris JM, Diskin SJ, Bosse KR. germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. Biorxiv : the Preprint Server For Biology. PMID 36778420 DOI: 10.1101/2023.01.31.525066 |
0.711 |
|
| 2023 |
Kim J, Vaksman Z, Egolf LE, Kaufman R, Evans JP, Conkrite KL, Danesh A, Lopez G, Randall MP, Dent MH, Farra LM, Menghani N, Dymek M, Desai H, Hausler R, ... ... Diskin SJ, et al. Germline pathogenic variants in 786 neuroblastoma patients. Medrxiv : the Preprint Server For Health Sciences. PMID 36747619 DOI: 10.1101/2023.01.23.23284864 |
0.666 |
|
| 2022 |
Stundon JL, Ijaz H, Gaonkar KS, Kaufman RS, Jin R, Karras A, Vaksman Z, Kim J, Corbett RJ, Lueder MR, Miller DP, Guo Y, Santi M, Li M, Lopez G, ... ... Diskin SJ, et al. ALT in Pediatric High-Grade Gliomas Can Occur without ATRX Mutation and is Enriched in Patients with Pathogenic Germline MMR Variants. Neuro-Oncology. PMID 36541551 DOI: 10.1093/neuonc/noac278 |
0.681 |
|
| 2022 |
Formicola D, Lasorsa VA, Cantalupo S, Testori A, Cardinale A, Avitabile M, Diskin S, Iolascon A, Capasso M. is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity. Hgg Advances. 4: 100158. PMID 36425957 DOI: 10.1016/j.xhgg.2022.100158 |
0.305 |
|
| 2022 |
Chang X, Liu Y, Glessner J, Hou C, Qu H, Nguyen K, Sleiman P, Lee L, Diskin SJ, Maris JM, Hakonarson H. Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma. Journal of the National Cancer Institute. PMID 35134187 DOI: 10.1093/jnci/djac012 |
0.34 |
|
| 2022 |
Testori A, Vaksman Z, Diskin SJ, Hakonarson H, Capasso M, Iolascon A, Maris JM, Devoto M. Genetic analysis in African American children supports ancestry specific neuroblastoma susceptibility. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35131881 DOI: 10.1158/1055-9965.EPI-21-0782 |
0.651 |
|
| 2021 |
Gamble LD, Purgato S, Henderson MJ, Di Giacomo S, Russell AJ, Pigini P, Murray J, Valli E, Milazzo G, Giorgi FM, Cowley M, Ashton LJ, Bhalshankar J, Schleiermacher G, Rihani A, ... ... Diskin SJ, et al. A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. Cancers. 13. PMID 33918978 DOI: 10.3390/cancers13081807 |
0.664 |
|
| 2020 |
Zhang C, Ostrom QT, Semmes EC, Ramaswamy V, Hansen HM, Morimoto L, de Smith AJ, Pekmezci M, Vaksman Z, Hakonarson H, Diskin SJ, Metayer C, Taylor MD, Wiemels JL, et al. Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma. Acta Neuropathologica Communications. 8: 173. PMID 33115534 DOI: 10.1186/s40478-020-01038-w |
0.687 |
|
| 2020 |
Lopez G, Conkrite KL, Doepner M, Rathi KS, Modi A, Vaksman Z, Farra L, Hyson E, Noureddine M, Wei JS, Smith MA, Asgharzadeh S, Seeger R, Khan JS, Guidry Auvil JM, ... ... Diskin SJ, et al. Somatic structural variation targets neurodevelopmental genes and identifies as a tumor suppressor in neuroblastoma. Genome Research. PMID 32796005 DOI: 10.1101/Gr.252106.119 |
0.748 |
|
| 2020 |
Zhang C, Ostrom QT, Hansen HM, Gonzalez-Maya J, Hu D, Ziv E, Morimoto L, de Smith AJ, Muskens IS, Kline CN, Vaksman Z, Hakonarson H, Diskin SJ, Kruchko C, Barnholtz-Sloan JS, et al. European genetic ancestry associated with risk of childhood ependymoma. Neuro-Oncology. PMID 32607579 DOI: 10.1093/Neuonc/Noaa130 |
0.709 |
|
| 2020 |
Koneru B, Lopez G, Farooqi A, Conkrite KL, Nguyen TH, Macha SJ, Modi A, Rokita JL, Urias E, Hindle A, Davidson H, Mccoy K, Nance J, Yazdani V, Irwin MS, ... ... Diskin SJ, et al. Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma. Cancer Research. PMID 32291317 DOI: 10.1158/0008-5472.Can-19-3068 |
0.423 |
|
| 2020 |
Chang X, Bakay M, Liu Y, Glessner J, Rathi KS, Hou C, Qu H, Vaksman Z, Nguyen K, Sleiman PMA, Diskin SJ, Maris JM, Hakonarson H. Mitochondrial DNA haplogroups and susceptibility to neuroblastoma. Journal of the National Cancer Institute. PMID 32096864 DOI: 10.1093/Jnci/Djaa024 |
0.635 |
|
| 2019 |
Rokita JL, Rathi KS, Cardenas MF, Upton KA, Jayaseelan J, Cross KL, Pfeil J, Egolf LE, Way GP, Farrel A, Kendsersky NM, Patel K, Gaonkar KS, Modi A, Berko ER, ... ... Diskin SJ, et al. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Reports. 29: 1675-1689.e9. PMID 31693904 DOI: 10.1016/J.Celrep.2019.09.071 |
0.711 |
|
| 2019 |
Ijaz H, Koptyra M, Gaonkar KS, Rokita JL, Baubet VP, Tauhid L, Zhu Y, Brown M, Lopez G, Zhang B, Diskin SJ, Vaksman Z, Mason JL, Appert E, Lilly J, et al. Pediatric High Grade Glioma Resources from the Children's Brain Tumor Tissue Consortium (Cbttc). Neuro-Oncology. PMID 31613963 DOI: 10.1093/Neuonc/Noz192 |
0.675 |
|
| 2019 |
Avitabile M, Succoio M, Testori A, Cardinale A, Vaksman Z, Lasorsa VA, Cantalupo S, Esposito M, Cimmino F, Montella A, Formicola D, Koster J, Andreotti V, Ghiorzo P, Romano MF, ... ... Diskin S, et al. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene. Carcinogenesis. PMID 31605138 DOI: 10.1093/Carcin/Bgz153 |
0.75 |
|
| 2019 |
Testori A, Lasorsa VA, Cimmino F, Cantalupo S, Cardinale A, Avitabile M, Limongelli G, Russo MG, Diskin S, Maris J, Devoto M, Keavney B, Cordell HJ, Iolascon A, Capasso M. Exploring shared susceptibility between two neural crest cells originating conditions: neuroblastoma and congenital heart disease Genes. 10: 663. PMID 31480262 DOI: 10.3390/Genes10090663 |
0.414 |
|
| 2019 |
Egolf LE, Vaksman Z, Lopez G, Rokita JL, Modi A, Basta PV, Hakonarson H, Olshan AF, Diskin SJ. Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma. American Journal of Human Genetics. PMID 31474320 DOI: 10.1016/J.Ajhg.2019.07.020 |
0.74 |
|
| 2019 |
Mazul AL, Weinberg CR, Engel SM, Siega-Riz AM, Zou F, Carrier KS, Basta PV, Vaksman Z, Maris JM, Diskin SJ, Maxen C, Naranjo A, Olshan AF. Neuroblastoma in relation to joint effects of vitamin A and maternal and offspring variants in vitamin A-related genes: A report of the Children's Oncology Group. Cancer Epidemiology. 61: 165-171. PMID 31279991 DOI: 10.1016/J.Canep.2019.06.009 |
0.676 |
|
| 2019 |
Taylor DM, Aronow BJ, Tan K, Bernt K, Salomonis N, Greene CS, Frolova A, Henrickson SE, Wells A, Pei L, Jaiswal JK, Whitsett J, Hamilton KE, MacParland SA, Kelsen J, ... ... Diskin SJ, et al. The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution. Developmental Cell. PMID 30930166 DOI: 10.1016/J.Devcel.2019.03.001 |
0.584 |
|
| 2019 |
Oldridge DA, Truong B, Russ D, DuBois SG, Vaksman Z, Mosse YP, Diskin SJ, Maris JM, Matthay KK. Differences in Genomic Profiles and Outcomes between Thoracic and Adrenal Neuroblastoma. Journal of the National Cancer Institute. PMID 30793172 DOI: 10.1093/Jnci/Djz027 |
0.697 |
|
| 2019 |
Weiner AK, Radaoui AB, Kendsersky NM, Harenza-Rokita JL, Sidoli S, Conkrite KL, Vaksman Z, Rathi K, Raman P, Martinez D, Bhatti T, Tsang M, Pawel B, Garcia BA, Maris JM, ... Diskin SJ, et al. Abstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma Cancer Research. 79: 3650-3650. DOI: 10.1158/1538-7445.Am2019-3650 |
0.698 |
|
| 2019 |
Weiner AK, Radaoui AB, Tsang M, Martinez D, Sidoli S, Conkrite KL, Delaidelli A, Rokita JL, Lane MV, Vaksman Z, Rathi KS, Raman P, Pogoriler J, Bhatti T, Pawel B, ... ... Diskin SJ, et al. Abstract LB-B04: A multi-omic surfaceome study identifies DLK1 as an epigenetically regulated protein and immunotherapeutic target in neuroblastoma Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-Lb-B04 |
0.699 |
|
| 2019 |
Zhang C, Ostrom Q, Hansen H, de Smith A, Kline C, Kruchko C, Vaksman Z, Diskin S, Barnholtz-Sloan J, Ramaswamy V, Taylor M, Bondy M, Metayer C, Wiemels J, Walsh K. PDTM-33. EUROPEAN GENETIC ANCESTRY ASSOCIATED WITH RISK OF CHILDHOOD EPENDYMOMA Neuro-Oncology. 21: vi194-vi194. DOI: 10.1093/Neuonc/Noz175.809 |
0.72 |
|
| 2019 |
Ijaz H, Koptyra M, Gaonkar K, Rokita JL, Baubet V, Tauhid L, Zhu Y, Brown M, Lopez G, Zhang B, Diskin S, Vaksman Z, Mason J, Appert E, Lilly J, et al. Pdtm-16. Pediatric High Grade Glioma Resources From The Children’S Brain Tumor Tissue Consortium (Cbttc) And Pediatric Brain Tumor Atlas (Pbta) Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.792 |
0.669 |
|
| 2018 |
Cimmino F, Avitabile M, Diskin SJ, Vaksman Z, Pignataro P, Formicola D, Cardinale A, Testori A, Koster J, de Torres C, Devoto M, Maris JM, Iolascon A, Capasso M. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor. International Journal of Cancer. PMID 30132831 DOI: 10.1002/Ijc.31822 |
0.745 |
|
| 2018 |
Ritenour LE, Randall MP, Bosse KR, Diskin SJ. Genetic susceptibility to neuroblastoma: current knowledge and future directions. Cell and Tissue Research. 372: 287-307. PMID 29589100 DOI: 10.1007/S00441-018-2820-3 |
0.397 |
|
| 2018 |
Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, ... ... Diskin SJ, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. PMID 29489755 DOI: 10.1038/Nature25795 |
0.376 |
|
| 2017 |
Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Maris JM, Diskin SJ, Onel K, Cohn SL. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma. Journal of the National Cancer Institute. 109. PMID 29117357 DOI: 10.1093/Jnci/Djx093 |
0.72 |
|
| 2017 |
Chang X, Zhao Y, Hou C, Glessner J, McDaniel L, Diamond MA, Thomas K, Li J, Wei Z, Liu Y, Guo Y, Mentch FD, Qiu H, Kim C, Evans P, ... ... Diskin SJ, et al. Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk. Nature Communications. 8: 569. PMID 28924153 DOI: 10.1038/S41467-017-00408-8 |
0.698 |
|
| 2017 |
Capasso M, McDaniel LD, Cimmino F, Cirino A, Formicola D, Russell MR, Raman P, Cole KA, Diskin SJ. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. Journal of Cellular and Molecular Medicine. PMID 28667701 DOI: 10.1111/Jcmm.13226 |
0.435 |
|
| 2017 |
McDaniel LD, Conkrite KL, Chang X, Capasso M, Vaksman Z, Oldridge DA, Zachariou A, Horn M, Diamond M, Huo C, Iolascon A, Hakonarson H, Rahman N, Devoto M, Diskin SJ. Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma. Plos Genetics. 13: e1006787. PMID 28545128 DOI: 10.1371/Journal.Pgen.1006787 |
0.72 |
|
| 2017 |
Vaksman Z, McDaniel LD, Diamond M, Maris JM, Diskin SJ. Abstract 690: Identifying the genetic basis of stage 4S neuroblastoma Cancer Research. 77: 690-690. DOI: 10.1158/1538-7445.Am2017-690 |
0.716 |
|
| 2017 |
Weiner AK, Sidoli S, Glisovic-Aplenc T, Maris JM, Garcia BA, Diskin SJ. Abstract 684: Integrative proteomics and transcriptomics to define the cell surface landscape of neuroblastoma Cancer Research. 77: 684-684. DOI: 10.1158/1538-7445.Am2017-684 |
0.334 |
|
| 2017 |
Lopez G, Conkrite K, Hong K, Harenza JL, Maris JM, Diskin S. Abstract 4881: Dissecting telomere maintenance mechanisms in neuroblastoma Cancer Research. 77: 4881-4881. DOI: 10.1158/1538-7445.Am2017-4881 |
0.414 |
|
| 2017 |
Evans JP, Patidar R, Vaksman Z, Sindiri S, Stewart DR, Khan J, Wei JS, Diskin SJ. Abstract 2591: A guide to filtering TARGET Complete Genomics germline variants Cancer Research. 77: 2591-2591. DOI: 10.1158/1538-7445.Am2017-2591 |
0.665 |
|
| 2016 |
Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. European Journal of Cancer (Oxford, England : 1990). 72: 177-185. PMID 28033528 DOI: 10.1016/J.Ejca.2016.11.022 |
0.698 |
|
| 2016 |
Mazul AL, Siega-Riz AM, Weinberg CR, Engel SM, Zou F, Carrier KS, Basta PV, Vaksman Z, Maris JM, Diskin SJ, Maxen C, Naranjo A, Olshan AF. A family-based study of gene variants and maternal folate and choline in neuroblastoma: a report from the Children's Oncology Group. Cancer Causes & Control : Ccc. PMID 27541142 DOI: 10.1007/S10552-016-0799-1 |
0.687 |
|
| 2016 |
Bai HX, Lee AM, Yang L, Zhang P, Davatzikos C, Maris JM, Diskin SJ. Imaging genomics in cancer research: limitations and promises. The British Journal of Radiology. 20151030. PMID 26864054 DOI: 10.1259/Bjr.20151030 |
0.304 |
|
| 2016 |
Applebaum MA, Vaksman Z, Hungate E, Henderson TO, London WB, Pinto NR, Volchenboum SL, Park JR, Naranjo A, Pearson AD, Hero B, Cohn SL, Diskin S. Second malignancies in patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project. Journal of Clinical Oncology. 34: 10547-10547. DOI: 10.1200/Jco.2016.34.15_Suppl.10547 |
0.671 |
|
| 2015 |
Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, McDaniel LD, Diamond M, Hart LS, Zhu S, Durbin AD, Abraham BJ, Anders L, Tian L, Zhang S, ... ... Diskin SJ, et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature. PMID 26560027 DOI: 10.1038/Nature15540 |
0.411 |
|
| 2015 |
Schnepp RW, Khurana P, Attiyeh EF, Raman P, Chodosh SE, Oldridge DA, Gagliardi ME, Conkrite KL, Asgharzadeh S, Seeger RC, Madison BB, Rustgi AK, Maris JM, Diskin SJ. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell. 28: 599-609. PMID 26481147 DOI: 10.1016/J.Ccell.2015.09.012 |
0.318 |
|
| 2015 |
Eleveld TF, Oldridge DA, Bernard V, Koster J, Daage LC, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Né P, Michon J, Pugh TJ, et al. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nature Genetics. PMID 26121087 DOI: 10.1038/Ng.3333 |
0.331 |
|
| 2015 |
Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei JS, Zhang S, Gnanchandran J, Seeger R, Asgharzadeh S, Khan J, ... Diskin SJ, et al. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Research. PMID 26100672 DOI: 10.1158/0008-5472.Can-14-3613 |
0.424 |
|
| 2015 |
Jiang Y, Oldridge DA, Diskin SJ, Zhang NR. CODEX: a normalization and copy number variation detection method for whole exome sequencing. Nucleic Acids Research. 43: e39. PMID 25618849 DOI: 10.1093/Nar/Gku1363 |
0.334 |
|
| 2015 |
Applebaum MA, Henderson TO, London WB, Pinto NR, Volchenboum SL, Park JR, Naranjo A, Pearson AD, Hero B, Diskin S, Cohn SL. Second malignancies in neuroblastoma patients: A report from the International Neuroblastoma Risk Group. Journal of Clinical Oncology. 33: 10019-10019. DOI: 10.1200/Jco.2015.33.15_Suppl.10019 |
0.35 |
|
| 2015 |
Lopez G, Alvarez M, Chen J, Rajbhandari P, Cole KA, Attiyeh EF, Diskin S, Mestdagh P, Vandesompele J, Maris JM, Califano A. Abstract PR10: Oncogenic dysregulations in neuroblastoma are associated with distal large chromosomal aberrations Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr10 |
0.417 |
|
| 2015 |
Jiang Y, Oldridge DA, Diskin SJ, Zhang NR. Abstract 4868: CODEX: a normalization and copy number variation detection method for whole-exome sequencing Cancer Research. 75: 4868-4868. DOI: 10.1158/1538-7445.Am2015-4868 |
0.359 |
|
| 2015 |
Conkrite K, Ferraro N, McDaniel L, Oldridge DA, Attiyeh E, Asgharzadeh S, Diamond M, Auvil JG, Davidsen T, Smith M, London WB, Seeger R, Khan J, Gerhard DS, Maris JM, ... Diskin SJ, et al. Abstract 475: Identification of SHANK2 as a tumor suppressor disrupted by recurrent somatic structural variation (SV) in neuroblastoma Cancer Research. 75: 475-475. DOI: 10.1158/1538-7445.Am2015-475 |
0.455 |
|
| 2015 |
Schnepp RW, Khurana P, Attiyeh EF, Chodosh S, Raman P, Oldridge DA, Gagliardi ME, Conkrite K, Asgharzadeh S, Seeger RC, Madison B, Rustgi A, Maris JM, Diskin SJ. Abstract 4734: A LIN28B/RAN/AURKA signaling network promotes neuroblastoma tumorigenesis Cancer Research. 75: 4734-4734. DOI: 10.1158/1538-7445.Am2015-4734 |
0.424 |
|
| 2015 |
Russell MR, Penikis A, Oldridge D, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei J, Zhang S, Gnanachandran J, Seeger R, Asgharzadeh S, Khan J, ... Diskin S, et al. Abstract 144: CASC15 is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus Cancer Research. 75: 144-144. DOI: 10.1158/1538-7445.Am2015-144 |
0.489 |
|
| 2014 |
Capasso M, Diskin S, Cimmino F, Acierno G, Totaro F, Petrosino G, Pezone L, Diamond M, McDaniel L, Hakonarson H, Iolascon A, Devoto M, Maris JM. Common genetic variants in NEFL influence gene expression and neuroblastoma risk. Cancer Research. 74: 6913-24. PMID 25312269 DOI: 10.1158/0008-5472.Can-14-0431 |
0.449 |
|
| 2014 |
Diskin SJ, Capasso M, Diamond M, Oldridge DA, Conkrite K, Bosse KR, Russell MR, Iolascon A, Hakonarson H, Devoto M, Maris JM. Rare variants in TP53 and susceptibility to neuroblastoma. Journal of the National Cancer Institute. 106: dju047. PMID 24634504 DOI: 10.1093/Jnci/Dju047 |
0.411 |
|
| 2014 |
Pinto N, Gamazon ER, Antao N, Myers J, Stark AL, Konkashbaev A, Im HK, Diskin SJ, London WB, Ludeman SM, Maris JM, Cox NJ, Cohn SL, Dolan ME. Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients. Clinical Pharmacology and Therapeutics. 95: 644-52. PMID 24549002 DOI: 10.1038/Clpt.2014.37 |
0.438 |
|
| 2014 |
Oldridge DA, Wood A, Winter C, Diamond M, Crimmins I, Zhang S, Wei J, Khan J, Capasso M, Rahman N, Diskin SJ, Maris JM. Abstract A27: A noncoding polymorphism in a GATA-containing enhancer element drives the association of LMO1 with neuroblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A27 |
0.466 |
|
| 2014 |
Russell MR, Penikis A, Oldridge D, Diamond M, Diskin S, Maris J, Cole K. Abstract 5237: The long intergenic noncoding RNA LINC00340 is a neuroblastoma susceptibility gene Cancer Research. 74: 5237-5237. DOI: 10.1158/1538-7445.Am2014-5237 |
0.429 |
|
| 2014 |
Wei JS, Patidar R, Shern J, Zhang S, Pugh T, Diskin SJ, Sindiri S, Song YK, Liao H, Wen X, Wang J, Skapek SX, Anderson JR, Barr FG, Seeger RC, et al. Abstract 5081: Systematic identification of germline mutations in rhabdomyosarcoma and neuroblastoma using massively paralleled sequencing Cancer Research. 74: 5081-5081. DOI: 10.1158/1538-7445.Am2014-5081 |
0.401 |
|
| 2014 |
Altman BJ, Hsieh A, Gouw AM, Stine ZE, Venkataraman A, Bellovin DI, Diskin SJ, Lu W, Zhang S, Felsher DW, Maris JM, Lazar MA, Rabinowitz JD, Hogenesch JB, Dang CV. Abstract 2953: Rev-erbα modulates Myc-driven cancer cell growth and altered metabolism Cancer Research. 74: 2953-2953. DOI: 10.1158/1538-7445.Am2014-2953 |
0.308 |
|
| 2013 |
Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, ... ... Diskin SJ, et al. The genetic landscape of high-risk neuroblastoma. Nature Genetics. 45: 279-84. PMID 23334666 DOI: 10.1038/Ng.2529 |
0.386 |
|
| 2013 |
Gamazon ER, Pinto N, Konkashbaev A, Im HK, Diskin SJ, London WB, Maris JM, Dolan ME, Cox NJ, Cohn SL. Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival. Journal of the National Cancer Institute. 105: 302-9. PMID 23243203 DOI: 10.1093/Jnci/Djs503 |
0.455 |
|
| 2013 |
Capasso M, Diskin SJ, Totaro F, Longo L, De Mariano M, Russo R, Cimmino F, Hakonarson H, Tonini GP, Devoto M, Maris JM, Iolascon A. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis. 34: 605-11. PMID 23222812 DOI: 10.1093/Carcin/Bgs380 |
0.468 |
|
| 2013 |
Pineros VM, Bosse KR, Hart LS, Diskin SJ, Rader J, Maris JM. Abstract 3816: DNA variation at BARD1 predicts response to aurora kinase inhibition in neuroblastoma. Cancer Research. 73: 3816-3816. DOI: 10.1158/1538-7445.Am2013-3816 |
0.367 |
|
| 2013 |
Diskin SJ, Capasso M, Diamond M, Bosse K, Hakonarson H, Devoto M, Maris JM. Abstract 3811: Rare variants at 16p11.2 and withinTP53influence neuroblastoma susceptibility. Cancer Research. 73: 3811-3811. DOI: 10.1158/1538-7445.Am2013-3811 |
0.462 |
|
| 2013 |
Wood AC, Pugh TJ, Morozova O, Koster J, Molenaar JJ, Pineros V, Bosse KR, Perin JC, Diskin S, Diamond MA, Marra M, Meyerson M, Versteeg R, Maris JM. Abstract 3804: Rare DNA variants are enriched at the BARD1 locus and likely influence neuroblastoma susceptibility. Cancer Research. 73: 3804-3804. DOI: 10.1158/1538-7445.Am2013-3804 |
0.451 |
|
| 2012 |
Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, Diamond M, Carpenter EL, Winter C, Lee H, Jagannathan J, Latorre V, Iolascon A, Hakonarson H, Devoto M, et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nature Genetics. 44: 1126-30. PMID 22941191 DOI: 10.1038/Ng.2387 |
0.446 |
|
| 2012 |
Bosse KR, Diskin SJ, Cole KA, Wood AC, Schnepp RW, Norris G, Nguyen le B, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh EF, Mosse YP, Pineros V, et al. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Research. 72: 2068-78. PMID 22350409 DOI: 10.1158/0008-5472.Can-11-3703 |
0.448 |
|
| 2012 |
Latorre V, Diskin SJ, Diamond MA, Zhang H, Hakonarson H, Maris JM, Devoto M. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 658-63. PMID 22328350 DOI: 10.1158/1055-9965.Epi-11-0830 |
0.412 |
|
| 2012 |
Pinto NR, Gamazon ER, Konkashbaev A, Im HK, Diskin S, London WB, Maris JM, Dolan ME, Cox NJ, Cohn SL. Relationship of divergent ancestral genetic variation on chromosome 6p22 and racial disparities in survival in neuroblastoma. Journal of Clinical Oncology. 30: 9516-9516. DOI: 10.1200/Jco.2012.30.15_Suppl.9516 |
0.415 |
|
| 2012 |
Sotillo-Piñeiro E, Xu L, Nguyen L, Laver T, Attiyeh E, Cole K, Diskin S, Maris J, Thomas-Tikhonenko A. Abstract LB-475: 3′UTR polymorphisms affect expression and activity of IGF1R, a therapeutic target in pediatric neuroblastoma Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-475 |
0.405 |
|
| 2012 |
Diskin SJ, Capasso M, Latorre V, Schnepp R, Attiyeh EF, Diamond M, Hou C, Carpenter EL, Lee H, Cole KA, Asgharzadeh S, Hakonarson H, Devoto M, Maris JM. Abstract 4871: New neuroblastoma susceptibility loci at 6q21 withinHACE1andLIN28B Cancer Research. 72: 4871-4871. DOI: 10.1158/1538-7445.Am2012-4871 |
0.49 |
|
| 2012 |
Pinto N, Gamazon ER, Im HK, Konkashbaev A, Cox NJ, Dolan ME, Diskin SJ, London WB, Maris JM, Cohn SL. Abstract 2486: African ancestry is associated with high-risk disease and event-free survival in children with neuroblastoma Cancer Research. 72: 2486-2486. DOI: 10.1158/1538-7445.Am2012-2486 |
0.437 |
|
| 2011 |
Nguyen le B, Diskin SJ, Capasso M, Wang K, Diamond MA, Glessner J, Kim C, Attiyeh EF, Mosse YP, Cole K, Iolascon A, Devoto M, Hakonarson H, Li HK, Maris JM. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. Plos Genetics. 7: e1002026. PMID 21436895 DOI: 10.1371/Journal.Pgen.1002026 |
0.494 |
|
| 2011 |
Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, Diskin SJ, Attiyeh EF, Sennett R, Norris G, Laudenslager M, Wood AC, Mayes PA, Jagannathan J, Winter C, et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 108: 3336-41. PMID 21289283 DOI: 10.1073/Pnas.1012351108 |
0.35 |
|
| 2011 |
Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 469: 216-20. PMID 21124317 DOI: 10.1038/Nature09609 |
0.502 |
|
| 2011 |
Morozova O, Birol I, Corbett R, Mungall K, Attiyeh EF, Asgharzadeh S, Zhao Y, Moore RA, Hirst M, Jones S, Hogarty MD, Diskin S, Mosse YP, Diamond M, Sposto R, et al. Abstract 926: Whole genome and transcriptome sequencing defines the spectrum of somatic changes in high-risk neuroblastoma Cancer Research. 71: 926-926. DOI: 10.1158/1538-7445.Am2011-926 |
0.422 |
|
| 2011 |
Pugh TJ, Lawrence M, Sougnez C, Getz G, Attiyeh E, Hogarty M, Diskin S, Yael M, Diamond M, Asgharzadeh S, Sposto R, Wei JS, Badgett T, London WB, Gastier-Foster J, et al. Abstract 4756: Exome sequencing of 81 neuroblastomas identifies a wide diversity of somatic mutation Cancer Research. 71: 4756-4756. DOI: 10.1158/1538-7445.Am2011-4756 |
0.426 |
|
| 2011 |
Pinto NR, Gamazon ER, Konkashbaev A, Cox NJ, Dolan ME, Diskin SJ, London WB, Devoto M, Maris JM, Cohn SL. Abstract A46: Genomic ancestry is associated with risk group and survival in children with neuroblastoma Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-A46 |
0.454 |
|
| 2010 |
Capasso M, Diskin SJ. Genetics and genomics of neuroblastoma Cancer Treatment and Research. 155: 65-84. PMID 20517688 DOI: 10.1007/978-1-4419-6033-7_4 |
0.493 |
|
| 2010 |
Cole KA, Huggins J, Laquaglia M, Diskin S, Attiyeh EF, Hulderman C, Han M, Bosse K, Jagannathan J, Mosse YP, Mayes P, Maris JM. Abstract 5263: An RNAi screen of the protein kinome identifiesCHEK1as a therapeutic target in neuroblastoma Cancer Research. 70: 5263-5263. DOI: 10.1158/1538-7445.Am10-5263 |
0.333 |
|
| 2010 |
Attiyeh EF, Hogarty MD, Mossé YP, Diskin SJ, Hakonarson H, Asgharzadeh S, Sposto R, London WB, Gastier-Foster JM, Gerhard DS, Smith MA, Zhang J, Khan J, Seeger RC, Maris JM. Abstract 5258: Genomic characterization and targeted resequencing of high-risk neuroblastoma (the neuroblastoma TARGET) Cancer Research. 70: 5258-5258. DOI: 10.1158/1538-7445.Am10-5258 |
0.441 |
|
| 2010 |
Mayes PA, Diskin S, Attiyeh EF, Toporovskaya Y, Maris JM. Abstract 5256: The identification of fatty acid synthase (FASN) as a candidate oncogene and therapeutic target in neuroblastoma Cancer Research. 70: 5256-5256. DOI: 10.1158/1538-7445.Am10-5256 |
0.408 |
|
| 2010 |
Diskin SJ, Jagganathan J, Diamond M, Hou C, Wang K, Zhang H, Li H, Mosse YP, Hakonarson H, Maris JM. Abstract 5253: Rare copy number variations (CNVs) influence neuroblastoma susceptibility Cancer Research. 70: 5253-5253. DOI: 10.1158/1538-7445.Am10-5253 |
0.443 |
|
| 2010 |
Nguyen LB, Diskin S, Hakonarson H, Maris JM, Li H. Abstract 4743: Genome-wide gene-centric discovery of disease variants in neuroblastoma Cancer Research. 70: 4743-4743. DOI: 10.1158/1538-7445.Am10-4743 |
0.357 |
|
| 2010 |
Diskin SJ, Bosse K, Mayes PA, LaQuaglia M, Attiyeh EF, Laudenslager M, Mosse YP, Diamond M, Belcastro L, Toporovskaya Y, Norris G, Hou C, Wang K, Zhang H, Kim C, et al. Abstract 3866: Identification ofNME7as a predisposition locus and candidate oncogene in neuroblastoma Cancer Research. 70: 3866-3866. DOI: 10.1158/1538-7445.Am10-3866 |
0.433 |
|
| 2009 |
Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K, Kim C, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 459: 987-91. PMID 19536264 DOI: 10.1038/Nature08035 |
0.434 |
|
| 2009 |
Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, Mosse YP, Kim C, Diskin SJ, Cole KA, Bosse K, Diamond M, Laudenslager M, Winter C, Bradfield JP, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nature Genetics. 41: 718-23. PMID 19412175 DOI: 10.1038/Ng.374 |
0.42 |
|
| 2009 |
Attiyeh EF, Diskin SJ, Attiyeh MA, Mossé YP, Hou C, Jackson EM, Kim C, Glessner J, Hakonarson H, Biegel JA, Maris JM. Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy. Genome Research. 19: 276-83. PMID 19141597 DOI: 10.1101/Gr.075671.107 |
0.398 |
|
| 2009 |
Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, Van De Wiel MA, Van Criekinge W, Thas O, Matthäi A, Cuesta MA, Droste JSTS, Craanen M, Schröck E, Ylstra B, Meijer GA. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression Gut. 58: 79-89. PMID 18829976 DOI: 10.1136/Gut.2007.143065 |
0.327 |
|
| 2008 |
Diskin SJ, Li M, Hou C, Yang S, Glessner J, Hakonarson H, Bucan M, Maris JM, Wang K. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Research. 36: e126. PMID 18784189 DOI: 10.1093/Nar/Gkn556 |
0.326 |
|
| 2008 |
Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Molecular Cancer Research : McR. 6: 735-42. PMID 18505919 DOI: 10.1158/1541-7786.Mcr-07-2102 |
0.309 |
|
| 2008 |
Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M, Winter C, Cole KA, Glessner JT, Kim C, Frackelton EC, et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. The New England Journal of Medicine. 358: 2585-93. PMID 18463370 DOI: 10.1056/Nejmoa0708698 |
0.348 |
|
| 2007 |
Guttman M, Mies C, Dudycz-Sulicz K, Diskin SJ, Baldwin DA, Stoeckert CJ, Grant GR. Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays. Plos Genetics. 3: e143. PMID 17722985 DOI: 10.1371/Journal.Pgen.0030143 |
0.366 |
|
| 2007 |
Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression Genes Chromosomes and Cancer. 46: 936-949. PMID 17647283 DOI: 10.1002/Gcc.20477 |
0.408 |
|
| 2007 |
Attiyeh EF, Mosse YP, Diskin S, Hou C, Attiyeh MA, Baker D, Strother D, Schmidt M, London WB, Maris JM. Identification of genomic DNA signatures predicting relapse in low- and intermediate-risk neuroblastoma using a case control design and high-density SNP genotyping: A Children's Oncology Group (COG) study Journal of Clinical Oncology. 25: 9500-9500. DOI: 10.1200/Jco.2007.25.18_Suppl.9500 |
0.45 |
|
| 2006 |
Diskin SJ, Eck T, Greshock J, Mosse YP, Naylor T, Stoeckert CJ, Weber BL, Maris JM, Grant GR. STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Research. 16: 1149-58. PMID 16899652 DOI: 10.1101/Gr.5076506 |
0.376 |
|
| 2006 |
Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Research. 66: 6050-62. PMID 16778177 DOI: 10.1158/0008-5472.Can-05-4618 |
0.418 |
|
| 2004 |
Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, deJong PJ, Zhao S, Liebman M, Weber BL. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis Genome Research. 14: 179-187. PMID 14672980 DOI: 10.1101/Gr.1847304 |
0.336 |
|
| 2002 |
Kissinger JC, Brunk BP, Crabtree J, Fraunholz MJ, Gajria B, Milgram AJ, Pearson DS, Schug J, Bahl A, Diskin SJ, Ginsburg H, Grant GR, Gupta D, Labo P, Li L, et al. The Plasmodium genome database. Nature. 419: 490-2. PMID 12368860 DOI: 10.1038/419490A |
0.307 |
|
| Show low-probability matches. |
